KROMATID to Present Breakthrough Genomic Integrity Benchmarking at ASGCT 2026, Powering the World’s First Genomic Intelligence Platform

BOULDER, Colo., April 30, 2026 /PRNewswire/ — KROMATID today announced it will present a transformative advancement in genomic integrity assessment at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting during the Analytics and Assay Development – Biosafety session….

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks